Clinical Trials Browser

Breast Neoplasms

NCT05278741 2025-12-26

BREAST

Phase NA Active not recruiting

32 enrolled

Breast

Breast Neoplasms

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Phase 2 Active not recruiting

35 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01723774 2025-12-09

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

Phase 2 Active not recruiting

84 enrolled 17 charts

Breast

Breast Neoplasms

NCT07253168 2025-11-28

TIGER-BC

Phase NA Not yet recruiting

240 enrolled

Breast

Breast Neoplasms

NCT07071402 2025-08-15

A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery

Phase NA Recruiting

120 enrolled

Breast

Breast Neoplasms

NCT06666517 2025-03-13

PERICAFS

Phase NA Completed

69 enrolled

Breast

Breast Neoplasms

NCT06447532 2025-03-12

INFLAMMATE

Enrolling by invitation

4,500 enrolled

Breast

Breast Neoplasms, Inflammation

NCT00182728 2024-10-01

NRR

Phase NA Completed

89 enrolled 10 charts

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

39 enrolled

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT06121557 2023-11-08

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Phase 1 Recruiting

24 enrolled

Breast

Breast Neoplasms

NCT05981001 2023-08-08

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Phase 1/2 Recruiting

170 enrolled

Breast

Breast Neoplasms

NCT02891759 2023-05-06

Compare Outcomes Between Two Acellular Dermal Matrices

Phase 2 Completed

320 enrolled

Breast

Breast Neoplasms

NCT02400658 2023-01-25

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

Phase NA Active not recruiting

358 enrolled

Breast

Breast Neoplasms

NCT05680194 2023-01-11

EEBC

Unknown

1,000 enrolled

Breast

Breast Neoplasms

NCT04698252 2022-08-08

LARA

Phase 2 Recruiting

74 enrolled

Breast

Breast Neoplasms

NCT01847001 2021-09-10

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Phase 2 Completed

10 enrolled 12 charts

Breast

Breast Neoplasms

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Phase 1/2 Completed

55 enrolled 10 charts

Breast

Breast Neoplasms

NCT03183206 2020-07-13

Safety and Efficiency of γδ T Cell Against Breast Cancer

Phase 1/2 Completed

100 enrolled

Breast

Breast Neoplasms

NCT04066790 2020-05-19

Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Phase 2 Terminated

12 enrolled

Breast

Breast Neoplasms

NCT02251353 2020-02-21

IMET

Unknown

300 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04086394 2020-02-20

PECS

Phase NA Unknown

130 enrolled

Breast

Breast Neoplasms, Pain, Pain, Postoperative

NCT00944047 2018-04-23

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

Phase 2 Completed

32 enrolled 7 charts

Breast

Breast Neoplasms

NCT01009437 2017-12-05

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Phase 1 Completed

28 enrolled

Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

NCT00855114 2017-12-02

Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT00450723 2017-02-07

Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

Phase NA Completed

39 enrolled 6 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01368263 2015-04-03

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Phase 2 Terminated

8 enrolled 5 charts

Breast

Breast Neoplasms

NCT00003050 2014-05-22

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

Phase 2 Completed

46 enrolled

Breast

Breast Neoplasms

NCT00842465 2013-11-25

Prolacsein

Completed

735 enrolled

Breast

Breast Diseases, Breast Neoplasms, Cystic Fibrosis

NCT00082667 2013-02-25

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Phase 2 Terminated

1 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00003953 2013-01-28

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Phase 2 Completed

39 enrolled

Breast

Breast Neoplasms

NCT00005800 2012-09-25

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Phase 2 Completed

45 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003035 2011-03-24

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

Phase 2 Completed

40 enrolled

Breast

Breast Neoplasms

Clinical Trials

OLIGAMI

BREAST

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

TIGER-BC

A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery

PERICAFS

INFLAMMATE

NRR

PITHAC

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Compare Outcomes Between Two Acellular Dermal Matrices

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

EEBC

LARA

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Safety and Efficiency of γδ T Cell Against Breast Cancer

Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

IMET

PECS

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

Prolacsein

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer